In disorders including cancer, heart disease and chemotherapy-induced cardiotoxicity, these methods target molecular dysregulations: i) MRX34: A miR-34 mimic created for cancer treatment, it demonstrated promise by regaining its ability to control tumor growth. This evidence concerns the gene IL1RAPL1 and heart disorder.